Streetbeat News

Products Services

RDHL

RedHill Biopharma Ltd's shares are trading higher after the company announced that its oral opaganib shows a significant increase in survival time in a U.S. Army-funded in vivo Ebola virus study. The study results showed a statistically significant survival increase in the 150 mg/kg opaganib group compared to the inactive vehicle control group. The company's shares are up 16.30% at $0.52 during the premarket session.

Portfolio Pulse from Vandana Singh

October 03, 2023 | 1:06 pm

SOUN

SSNLF

SoundHound AI, Inc. (NASDAQ:SOUN) and Samsung Electronics are partnering with White Castle to deploy voice AI-enabled dynamic drive-thru menu boards. The technology combines SoundHound's speech recognition and Samsung's MagicINFO digital signage software. The collaboration has resulted in orders processed in under 60 seconds and 90% order completion rates, exceeding previous staff-based benchmarks. SoundHound and Samsung plan to collaborate on future projects.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 1:05 pm

JBLU

UBER

Uber for Business and JetBlue have announced a partnership to offer complimentary Uber vouchers to JetBlue customers who experience qualified travel disruptions. The program is currently available across the U.S. in every city where JetBlue operates, with plans to expand internationally. The partnership aims to streamline the customer experience in the event of a flight delay or cancellation by directly emailing them their Uber voucher, saving customers time and limiting the need to use personal funds and request reimbursement from JetBlue.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 1:04 pm

CCLD

CareCloud, Inc. (NASDAQ:CCLD) announced that its medSR division has successfully implemented the MEDITECH Expanse electronic health record (EHR) system at Doctors Hospital Health System in the Bahamas. The new EHR system enhances patient care, data management, and disaster recovery capabilities. Doctors Hospital selected CareCloud's medSR for its expertise in healthcare IT implementation.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 1:02 pm

RAD

Rite Aid (NYSE:RAD) has announced the launch of Ello Market, a new exclusive collection of quality snacks and pantry staples. The collection includes a wide range of products from savory nuts to assorted sweets and cooking staples. The move is part of Rite Aid's strategy to cater to the evolving consumption habits of its customers.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 1:01 pm

BCTX

BriaCell Therapeutics has initiated a Phase 3 study of Bria-IMT in advanced metastatic breast cancer. The study, which is expected to enroll 354 patients, could result in full approval and marketing authorization for Bria-IMT if the results are positive. The study's primary endpoint is overall survival in patients treated with the Bria-IMT combination regimen versus those treated with physician's choice. The study initiation follows FDA Fast Track designation and earlier supportive Phase 2 safety and efficacy data.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 1:01 pm

ASAN

Asana, Inc. (ASAN) has announced new artificial intelligence (AI) capabilities to its enterprise work management solution. The new features, powered by Asana's Work Graph, aim to provide greater clarity, impact, and scale for executives, departments, and organizations. The AI capabilities include smart fields, smart editor, smart summaries, smart workflows, smart digests, smart status, smart answers, smart goals, smart planning, smart workload, and smart search. Asana also integrates with services like Amazon Web Services (AWS) AppFabric to improve collaboration at scale.

Portfolio Pulse from Benzinga Newsdesk

October 03, 2023 | 1:01 pm

ALXO

AZN

LLY

MRK

ALX Oncology Holdings Inc released interim Phase 2 data from its ASPEN-06 trial of evorpacept for HER2-positive gastric cancer, showing a 52% overall response rate. The results compare favorably to the efficacy reported for Eli Lilly's Cyramza. The trial included patients previously treated with AstraZeneca's Enhertu and Merck's Keytruda. ALXO plans to report the final analysis in Q2 2024 and initiate Phase 3 in late 2024. ALXO shares gained over 100% in premarket trading.

Portfolio Pulse from Vandana Singh

October 03, 2023 | 12:58 pm

CRWD

DASH

IYK

XHB

On CNBC's 'Halftime Report Final Trades', four assets were named as final trades: iShares US Consumer Staples ETF (IYK), DoorDash (DASH), SPDR S&P Homebuilders ETF (XHB), and CrowdStrike Holdings (CRWD). DoorDash, along with Uber and Grubhub, failed to overturn the New York City minimum wage, now required to pay food delivery workers a minimum of $17.96 per hour. CrowdStrike recently launched the first zero-code application development platform in cybersecurity.

Portfolio Pulse from Priya Nigam

October 03, 2023 | 12:57 pm

ABNB

Airbnb Inc (NASDAQ:ABNB) is facing challenges in 2023 due to host unrest, competitive pressures, and stringent regulations. The company's CEO, Brian Chesky, has proposed a series of site enhancements to address these issues, with a focus on quality, affordability, and customer service. AI is being used for listing verification and guest vetting. Despite regulatory challenges, particularly in New York, Chesky remains optimistic and is committed to enhancing core services and exploring the 'experiences' sector as an alternative growth avenue. Keybanc analyst Justin Patterson downgraded Airbnb from Overweight to Sector Weight.

Portfolio Pulse from Anusuya Lahiri

October 03, 2023 | 12:50 pm